2255 Glades Road
Suite 221A
Boca Raton, FL 33431
United States
410 598 9024
https://www.novelstem.com
Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Jan H. Loeb | Executive Chairman & President | N/D | N/D | 1959 |
Mr. Mitchell Rubenstein | Co-Founder & Independent Director | N/D | N/D | 1954 |
Ms. Christine Jenkins | VP, CFO & Secretary | 54k | N/D | 1964 |
Mr. David Collins | Investor Relations Firm, Catalyst IR | N/D | N/D | N/D |
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.
L'ISS Governance QualityScore di NovelStem International Corp. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.